Position in ZTS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$16,168
-$10,429 QoQ
Shares Held
225
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,211
of 1,408 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Coston, McIsaac & Partners holds $48,181 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (33.6% of the industry book) .
All Filings in ZTS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,168 | 225 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $26,597 | 225 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $28,309 | 225 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $34,092 | 233 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $34,932 | 224 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $36,881 | 224 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $36,496 | 224 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $43,765 | 224 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $38,832 | 224 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $37,733 | 223 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $44,013 | 223 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $38,797 | 223 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $38,402 | 223 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $37,116 | 223 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $37,077 | 253 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $37,517 | 253 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $43,488 | 253 | Shares | Sole | 2022-09-21 | |
| No filing history on record for this holder in this stock. | ||||||